Sangamo BioSciences, Inc.Richmond, CA, United States (NASDAQ (GM): SGMO)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Sangamo BioSciences Financial Statements

Sangamo BioSciences Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Sangamo BioSciences Income Statement

  2007 2006 2005
Revenue ($ mil.) 9.1 7.9 2.5
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (24.8) (20.7) (13.8)
Total Net Income ($ mil.) (21.5) (17.9) (13.3)
Diluted EPS (Net Income) (0.58) (0.55) (0.51)
More Sangamo BioSciences financial information

Sangamo BioSciences Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 2.8 2.8 2.8
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (8.0) (8.8) (7.6)
Total Net Income ($ mil.) (7.4) (8.0) (6.7)
Diluted EPS (Net Income) (0.18) (0.20) (0.17)
More Sangamo BioSciences financial information

Sangamo BioSciences Stock Quote & Chart

10/10/08 15:00:23 EST • NASDAQ • 6.37 • Increased by +0.3300 • Increased by +5.4636 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Sangamo BioSciences Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 40.10 3.44 1.55
Price/Earnings Ratio -- 15.44 15.69
Price/Book Ratio 7.08 2.92 1.50
Price/Cash Flow Ratio -- 12.54 9.64
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Sangamo BioSciences Financial Ratios

Sangamo BioSciences Competitive Intelligence

Eli Lilly Merck Pfizer
Annual Sales ($ mil.) 18,633.5 24,197.7 48,418.0
Employees 40,600 59,800 86,600
Market Cap ($ mil.) 54,027.9 74,986.6 128,618.2

Competitive Landscape